glp 1 and bleeding Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: A Cross-Sectional Analysis of the National Institutes of Health All of Us Cohort GLP-1 agonists and bleeding on

Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran

Walk daily, even lightly

Activated microglia secrete the chemokine CXCL2, which in turn upregulates ACSL4 expression and suppresses GPX4 activity in adjacent neurons, intensifying lipid peroxidation and membrane damage

Postpartum is a major hormonal transition, says Shapiro

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications with specific UK licences: some are approved for type 2 diabetes management (semaglutide [Ozempic], dulaglutide [Trulicity], liraglutide [Victoza]), while others are specifically licensed for weight management in adults with obesity or overweight with weight-related comorbidities (semaglutide [Wegovy], liraglutide [Saxenda])

Several indirect mechanisms may contribute to fatigue in patients taking GLP-1 receptor agonists